January 2019 FDA Recall Drug by Mcguff Compounding Pharmacy Services, Inc.
D-0802-2020 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Mcguff Compounding Pharmacy Services, Inc. on January 10, 2019 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0802-2020

Reason for Recall
Presence of Particulate Matter: filmy/cloudy particulate observed in vial.
Initiated
01-10-2019
Reported
01-22-2020
Quantity
146 30 ml vials were dispensed

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
McGuff Compounding Pharmacy Services, Inc.
Distributed Nationwide in the US
Lipoic Acid Injection (aka Alpha Lipoic Acid or Thioctic Acid), 1,200 mg/30 mL (40 mg/mL) Sterile 30 mL Multiple Dose Vial, Rx Only, McGuff Compounding Pharmacy Services, Inc., Santa Ana, CA 92704

Batch or Lot Expiration Information

Lot# : 18M0991, Preparation #: 390-2678, Beyond Usage Date: 06/15/2019